Skip to main content
Premium Trial:

Request an Annual Quote

HUGO, Affymetrix Sponsor Pacific Pan-Asian SNP

NEW YORK, Nov. 19 (GenomeWeb News) - A coalition of scientists from Asian countries are organizing the HUGO Pacific Pan-Asian SNP Initiative, which aims to provide a detailed, comprehensive picture of the genetic diversity in Asian populations.

 

Sponsored by the Human Genome Organization and Affymetrix, the pan-Asian project is expected to begin in the middle of 2005. The study will examine 50,000 SNPs in each study participant and will focus particularly on genetic differences that affect health. It will use SNP microarray technology made by Affymetrix, combined with semi-conductor manufacturing technology.

 

"The study will give scientists a 'genetic map' of human history in Asia, showing how nearly half of the world's population migrated throughout the region and settled to form the distinct cultures that we know today," said Edison Liu, executive director of the Genome Institute of Singapore.

 

Participating countries include China, India, Indonesia, Japan, Korea, Malaysia, Nepal, Philippines, Singapore, Thailand, and Taiwan.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.